Opthea Valuation
| OPTDelisted Stock | USD 3.41 0.07 2.01% |
At this time, the company appears to be fairly valued. Opthea holds a recent Real Value of $3.36 per share. The prevailing price of the company is $3.41. Our model determines the value of Opthea from analyzing the company fundamentals such as Current Valuation of 492.14 M, return on equity of -33.83, and Shares Owned By Institutions of 3.68 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Opthea's price fluctuation is very steady at this time. Calculation of the real value of Opthea is based on 3 months time horizon. Increasing Opthea's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Opthea's intrinsic value may or may not be the same as its current market price of 3.41, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.41 | Real 3.36 | Hype 3.41 | Naive 3.73 |
The intrinsic value of Opthea's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Opthea's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Opthea helps investors to forecast how Opthea stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Opthea more accurately as focusing exclusively on Opthea's fundamentals will not take into account other important factors: About Opthea Valuation
The delisted stock valuation mechanism determines Opthea's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Opthea based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Opthea. We calculate exposure to Opthea's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Opthea's related companies.Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia. Opthea operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Opthea Growth Indicators
Investing in growth stocks can be very risky. If the company such as Opthea does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 79.8 M | |
| Forward Price Earnings | 6.734 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Opthea Stock
If you are still planning to invest in Opthea check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Opthea's history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |